Contrast-Enhanced Ultrasound: Physics & Safety

Contrast-enhanced ultrasound images the contrast agent, not the tissue — and that single fact inverts the usual output settings. Where conventional ultrasound pushes acoustic output up for penetration, CEUS deliberately turns it down, running at a very low mechanical index so the microbubbles survive to be imaged in real time. Getting CEUS right means understanding the mechanical index, the acoustic-output ceilings that bound it, and the microbubble physics in between.

Introduction

Ultrasound contrast agents are suspensions of gas-filled microbubbles small enough to pass through the pulmonary circulation and circulate as a pure blood-pool tracer.¹⁰¹¹ Injected intravenously, they turn ordinary grayscale ultrasound into a real-time map of blood flow and tissue perfusion — characterizing a focal liver lesion by its enhancement pattern, opacifying the left ventricle in a difficult echocardiogram, or, instilled into the bladder, revealing vesicoureteral reflux in a child, all without ionizing radiation or nephrotoxic contrast.³⁷⁸

What makes CEUS distinctive as a physics problem is that the diagnostic signal comes from an object that the ultrasound beam can destroy. A microbubble is an exquisitely nonlinear scatterer, but drive it too hard and it collapses. The entire technique therefore lives at the low-output end of the acoustic scale, in a regime most sonographers spend their careers avoiding because it is too gentle for grayscale tissue imaging. The parameter that governs that regime is the mechanical index (MI), and reading it correctly is central to both image quality and safety.⁶¹²

This article explains what CEUS is, defines the mechanical index and the acoustic-output limits that bound it, works through the physics of low-MI contrast imaging, surveys the clinical applications and safety record, and lays out the QC and regulatory context. DRPS supports ultrasound programs as part of its ultrasound physics testing and medical physicist consulting services across Florida, Maryland, Virginia, Washington DC, California, and Nevada.

Topic Explanation

What is a microbubble contrast agent?

An ultrasound contrast agent is a suspension of encapsulated gas microbubbles, typically on the order of one to ten micrometers in diameter — similar in size to a red blood cell — so they remain entirely within the vascular space.¹⁰¹¹ A stabilizing shell of phospholipid or protein surrounds a low-solubility gas core such as sulfur hexafluoride or a perfluorocarbon, which resists dissolution long enough for a diagnostic exam.

The microbubbles matter because of how they respond to an ultrasound field. A gas bubble is far more compressible than the surrounding blood or tissue, so it expands and contracts strongly as the acoustic pressure wave passes. Crucially, that oscillation is nonlinear: the bubble does not simply mirror the driving pressure but generates harmonics — echoes at multiples of the transmitted frequency — that tissue does not produce nearly as strongly.¹⁰¹² Contrast-specific imaging modes exploit exactly this difference, using techniques such as pulse inversion and amplitude modulation to cancel the linear tissue echo and keep the nonlinear bubble signal. The result is an image in which flowing, bubble-filled blood is bright and static tissue is suppressed.¹²

Three agents are FDA-approved in the United States, and their approved indications differ in a way that is worth keeping straight.

All three carry a class boxed warning about rare but serious cardiopulmonary reactions, discussed in the safety section below.³

The output display standard

Because acoustic output determines both image quality and the potential for bioeffects, diagnostic ultrasound systems display two real-time safety indices: the thermal index (TI), which relates to tissue heating, and the mechanical index (MI), which relates to non-thermal, mechanical effects such as cavitation.¹ IEC 62359 defines the test methods for determining both indices, and the FDA marketing-clearance framework sets the acoustic-output ceilings a cleared system may reach.¹² For CEUS, the MI is the index that governs the technique, because the microbubble is itself a cavitation nucleus.

Key Technical Principles

Defining the mechanical index

The mechanical index is defined as the derated peak rarefactional (negative) acoustic pressure in megapascals, divided by the square root of the acoustic center frequency in megahertz:¹

Here $p_{r.3}$ is the peak rarefactional pressure derated to account for tissue attenuation along the beam path — the ".3" denotes derating at 0.3 dB·cm⁻¹·MHz⁻¹ — and $f_c$ is the center frequency. The rarefactional (negative-pressure) half-cycle is what pulls a bubble outward and can drive inertial cavitation, which is why the MI is built on it. The inverse-square-root frequency dependence reflects that, for a given pressure, lower frequencies are more likely to produce cavitation.¹¹²

A worked example makes the scale concrete. Suppose a contrast-specific preset produces a derated peak rarefactional pressure of 0.8 MPa at a center frequency of 4 MHz:

That value sits far below the FDA regulatory ceiling but, as the next section shows, is actually too high for continuous contrast imaging. The number that keeps the bubbles alive is several times smaller.

Acoustic-output limits

Diagnostic ultrasound operates under global acoustic-output ceilings. Under the FDA marketing-clearance framework, a cleared non-ophthalmic system must keep the derated spatial-peak temporal-average intensity at or below ISPTA.3 = 720 mW/cm², and must satisfy MI ≤ 1.9 (or, equivalently, a derated spatial-peak pulse-average intensity ISPPA.3 ≤ 190 W/cm²).² These are the regulatory maxima the machine may reach across all modes — not the operating point for CEUS. In practice, contrast imaging runs far below the MI ceiling, and the clinical skill is choosing an MI low enough to preserve the bubbles yet high enough to generate usable signal.

The low-MI regime that CEUS lives in

Here is the central tension of CEUS. The strength of the contrast signal grows with acoustic pressure, but so does bubble destruction. Push the MI up and the bubbles rupture; the image brightens for an instant and then goes dark as the contrast is consumed.¹² Contrast-specific real-time imaging therefore deliberately operates at very low MI — commonly around 0.1, and generally kept well below 0.3 — so the microbubbles oscillate and scatter their nonlinear harmonics without being destroyed, sustaining continuous perfusion imaging over many cardiac cycles.¹²¹⁴ The table below contrasts the two operating regimes.

The high-MI "flash" is not a mistake but a tool: a brief burst of high-output pulses intentionally destroys the microbubbles in the imaging plane, after which the operator watches fresh bubbles flow back in. The rate of that replenishment is a measure of perfusion. But between flashes, the exam returns to the low-MI regime, because the diagnostic information depends on the bubbles surviving.¹²

There is a signal-to-noise cost to running this gently. Very low MI means weak echoes, so contrast imaging trades acoustic drive for bubble preservation and accepts lower penetration and SNR than grayscale imaging at the same depth — a trade-off that modern contrast-specific sequences and beamforming work continuously to improve.¹² Understanding that trade-off is what separates a diagnostic CEUS study from a noisy or a bubble-starved one.

Clinical Impact

CEUS earns its place by adding real-time, radiation-free perfusion information to an exam the patient is often already having. In the liver, the arterial-, portal-, and late-phase enhancement pattern of a focal lesion is a well-validated basis for characterization, codified in international guidelines and in dedicated reporting schemes.⁷⁹ In echocardiography, left-ventricular opacification rescues nondiagnostic studies by delineating the endocardial border. In children, intravesical CEUS detects vesicoureteral reflux without ionizing radiation — a meaningful advantage in a young, often repeatedly imaged population.³⁸

The technique's value depends on the physics being right. If the MI is set too high, the study is bubble-starved and the enhancement pattern is unreliable; if contrast-specific processing is misconfigured, tissue is not suppressed and the perfusion signal is buried. The non-hepatic applications guideline and the liver guidelines both assume an operator who understands that low-MI, contrast-specific imaging is the operating point — which is precisely the knowledge a physics-informed QC and training program reinforces.⁷⁸ Emerging methods that push the same microbubble physics further, such as super-resolution and multiplane-wave contrast imaging, only raise the premium on correct acoustic-output settings.

Practical Tips

• Confirm the machine is in a contrast-specific mode at low MI. Real-time CEUS should show an MI on the order of 0.1, not a grayscale-level MI. A study inadvertently run at high MI will destroy contrast faster than it images it.
• Read the displayed MI and TI. These indices are the operator's real-time safety and technique feedback. Confirm they update sensibly as output and depth are changed, and that the CEUS preset does not silently exceed the intended low-MI operating point.
• Use the flash deliberately, not accidentally. Reserve high-MI bursts for destruction–replenishment assessment, and return to low MI afterward.
• Keep dose and exam time minimal. Consistent with prudent use, image with the lowest MI and the recommended contrast dose for the shortest time that answers the clinical question, particularly in cardiac imaging.
• Screen and prepare for reactions. Because the labels carry a boxed warning, confirm that trained personnel and resuscitation equipment are available during administration, especially in patients with unstable cardiopulmonary status.³
• Fold CEUS into routine ultrasound QC. Acoustic-output behavior, contrast-mode function, and image quality belong in the facility's periodic ultrasound testing, alongside the checks described in our guide to diagnostic ultrasound QC and ultrasound thermal and mechanical index safety.

Regulatory Considerations

CEUS is governed by the intersection of device acoustic-output regulation and drug labeling — the machine and the microbubble are regulated separately.

• Acoustic output (device side). The scanner is a diagnostic ultrasound device whose acoustic output is bounded by the FDA marketing-clearance framework (ISPTA.3 ≤ 720 mW/cm² and MI ≤ 1.9), with the displayed TI and MI determined by the IEC 62359 test methods.¹² These apply to the system regardless of whether contrast is used.
• Contrast agent (drug side). The microbubble agents are FDA-approved drugs with their own prescribing information, indications, and the class boxed warning on serious cardiopulmonary reactions; administration must follow the label and institutional policy.³
• Prudent use and bioeffects. With a gas-body contrast agent present, the threshold for confirmed biological effects is lower than for tissue alone. The AIUM statement on biological effects in tissues with ultrasound contrast agents reports that independently confirmed in-vivo bioeffects have occurred at an MI above 0.4 in the presence of a contrast agent, and advises using minimal MI, the recommended dose, and minimal exam time.⁴ This is consistent with — and reinforces — the low-MI operating point CEUS already uses for image-quality reasons.
• Safety record and screening. The agents are among the safest imaging contrast media: they are not nephrotoxic and require no renal-function screening, and large clinical series report serious adverse-reaction rates well under one percent.⁵¹³ The current multi-society consensus on safe administration provides the practical supervision and monitoring framework.⁶

Ultrasound is regulated as a device by the FDA and is non-ionizing, so it falls outside state radiation-machine registration and outside NRC materials rules; the binding quality framework for a CEUS program comes from accreditation and professional practice standards rather than a radiation-control agency. Always confirm accreditation-specific requirements with the relevant body. For where CEUS fits in a facility's accreditation posture, see our accreditation support services.

Frequently Asked Questions (FAQs)

Why does turning acoustic output up make a CEUS image worse?

Because the diagnostic signal comes from intact microbubbles. Higher acoustic output — a higher MI — destroys the bubbles, so the contrast brightens momentarily and then disappears. Contrast imaging depends on keeping the bubbles oscillating, not rupturing them, which requires low MI.

Is a higher mechanical index always more dangerous?

The MI estimates the likelihood of mechanical bioeffects, so a lower MI is generally gentler. With a microbubble agent present, the relevant caution threshold is lower than for tissue alone — confirmed bioeffects have been reported above an MI of 0.4 with contrast — which aligns with keeping CEUS at low MI for both image-quality and safety reasons.

Can any ultrasound machine do CEUS?

The system needs contrast-specific imaging modes (such as pulse inversion or amplitude modulation) and a low-MI contrast preset. Many modern systems include these, but the preset and acoustic-output behavior should be verified as part of QC rather than assumed.

Do ultrasound contrast agents affect the kidneys or thyroid?

No. Unlike iodinated CT contrast or gadolinium, microbubble ultrasound agents are not nephrotoxic and do not affect the thyroid, so no creatinine or renal screening is required before administration.

What is destruction–replenishment imaging?

It is a perfusion-quantification technique that briefly raises the MI to destroy the microbubbles in the imaging plane, then returns to low MI to watch fresh bubbles flow back in. The replenishment rate reflects tissue perfusion.

Key Takeaways

• CEUS images gas microbubbles, roughly red-blood-cell-sized, that circulate as a pure intravascular blood-pool tracer and scatter ultrasound nonlinearly.¹⁰¹¹¹²
• The mechanical index — derated peak rarefactional pressure divided by the square root of center frequency — governs the technique; the FDA ceiling is MI 1.9, but CEUS operates far lower.¹²
• Contrast-specific real-time imaging runs at very low MI, commonly around 0.1 and well below 0.3, so the microbubbles survive to be imaged.¹²¹⁴
• A deliberate high-MI "flash" destroys bubbles for destruction–replenishment perfusion measurement, after which imaging returns to low MI.¹²
• Ultrasound contrast agents are non-nephrotoxic with a strong safety record, but carry a boxed warning on rare serious cardiopulmonary reactions.³⁵¹³
• Displayed MI and TI, contrast-mode function, and acoustic output belong in routine ultrasound QC and accreditation.¹²

Conclusion

Contrast-enhanced ultrasound is a case study in matching the physics to the task. The microbubble is a powerful, nonlinear scatterer and, at the same time, a fragile one, so the whole technique is organized around a low mechanical index that keeps the bubbles intact. Understanding the MI — how it is defined, what limits bound it, and why CEUS lives near the bottom of the acoustic-output scale — is what turns contrast ultrasound from a temperamental mode into a reliable, radiation-free window on perfusion. A physics-informed QC and training program keeps the displayed indices honest and the operating point where it belongs.

How DRPS Can Help

Diagnostic Radiation Physics Services (DRPS) supports ultrasound and contrast-enhanced ultrasound programs across Florida, Maryland, Virginia, Washington DC, California, and Nevada with ultrasound physics testing, acoustic-output and image-quality evaluation, contrast-mode verification, accreditation support, and medical physicist consulting — all performed by board-certified medical physicists.

A CEUS program succeeds when the acoustic-output settings, the contrast-specific modes, and the displayed safety indices all behave as intended. DRPS helps facilities verify that the physics is right so the technique delivers dependable, low-dose perfusion imaging.

Related Resources

• Diagnostic ultrasound QC
• Ultrasound thermal and mechanical index safety
• Doppler ultrasound quality control
• Ultrasound transducer element testing
• Ultrasound elastography quality control
• Ultrasound physics testing
• Medical physicist consulting

References

1. International Electrotechnical Commission. Ultrasonics — Field characterization — Test methods for the determination of thermal and mechanical indices related to medical diagnostic ultrasonic fields. IEC 62359:2010+AMD1:2017 (Edition 2.1). Geneva: IEC. webstore.iec.ch
2. U.S. Food and Drug Administration. Marketing Clearance of Diagnostic Ultrasound Systems and Transducers — Guidance for Industry and FDA Staff. 2019. fda.gov
3. U.S. Food and Drug Administration. LUMASON (sulfur hexafluoride lipid-type A microspheres) Prescribing Information. Bracco Diagnostics; NDA 203684. accessdata.fda.gov
4. American Institute of Ultrasound in Medicine. Statement on Biological Effects in Tissues with Ultrasound Contrast Agents. AIUM Official Statement. aium.org
5. American College of Radiology. ACR Manual on Contrast Media — Ultrasound Contrast Media. acr.org
6. Strom JB, Appis A, Barr RG, et al. Multi-societal expert consensus statement on the safe administration of ultrasound contrast agents. Echo Res Pract. 2025;12(1):4. doi:10.1186/s44156-024-00068-7. doi.org
7. Dietrich CF, Nolsøe CP, Barr RG, et al. Guidelines and Good Clinical Practice Recommendations for Contrast-Enhanced Ultrasound (CEUS) in the Liver — Update 2020. Ultrasound Med Biol. 2020;46(10):2579-2604. doi:10.1016/j.ultrasmedbio.2020.04.030. doi.org
8. Sidhu PS, Cantisani V, Dietrich CF, et al. The EFSUMB Guidelines and Recommendations for the Clinical Practice of CEUS in Non-Hepatic Applications: Update 2017 (Long Version). Ultraschall Med. 2018;39(2):e2-e44. doi:10.1055/a-0586-1107. doi.org
9. Claudon M, Dietrich CF, Choi BI, et al. Guidelines and good clinical practice recommendations for contrast-enhanced ultrasound (CEUS) in the liver — update 2012. Ultrasound Med Biol. 2013;39(2):187-210. doi:10.1016/j.ultrasmedbio.2012.09.002. doi.org
10. Helfield B. A Review of Phospholipid Encapsulated Ultrasound Contrast Agent Microbubble Physics. Ultrasound Med Biol. 2019;45(2):282-300. doi:10.1016/j.ultrasmedbio.2018.09.020. doi.org
11. Stride E, Saffari N. Microbubble ultrasound contrast agents: a review. Proc Inst Mech Eng H. 2003;217(6):429-447. doi:10.1243/09544110360729072. doi.org
12. Burns PN. Instrumentation for contrast echocardiography. Echocardiography. 2002;19(3):241-258. doi:10.1046/j.1540-8175.2002.00241.x. doi.org
13. Piscaglia F, Bolondi L. The safety of Sonovue in abdominal applications: retrospective analysis of 23188 investigations. Ultrasound Med Biol. 2006;32(9):1369-1375. doi:10.1016/j.ultrasmedbio.2006.05.031. doi.org
14. Săftoiu A, Dietrich CF, Vilmann P. Contrast-enhanced harmonic endoscopic ultrasound. Endoscopy. 2012;44(6):612-617. doi:10.1055/s-0032-1308909. doi.org